Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Earnings Outlook For Aehr Test Systems

Aehr Test Systems (NASDAQ:AEHR) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Aehr Test Systems will report an earnings per share (EPS) of $0.14.

Earnings Preview: Chicken Soup for the Soul

Earnings Preview: Chicken Soup for the Soul

Chicken Soup for the Soul (NASDAQ:CSSE) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Chicken Soup for the Soul will report an earnings per share (EPS) of $-0.51.

Earnings Outlook For Acacia Research

Earnings Outlook For Acacia Research

Acacia Research (NASDAQ:ACTG) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Acacia Research will report an earnings per share (EPS) of $-0.04.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2022

Earnings Outlook For Affimed

Affimed (NASDAQ:AFMD) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Affimed will report an earnings per share (EPS) of $-0.17.

Analyst Ratings For 1Life Healthcare

1Life Healthcare (NASDAQ:ONEM) has observed the following analyst ratings within the last quarter:

A Preview Of Arco Platform's Earnings

Arco Platform (NASDAQ:ARCE) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Arco Platform will report an earnings per share (EPS) of $0.31.

inkl

Read news from The Economist, FT, and more,
with one subscription

Preview: Calithera Biosciences's Earnings

Preview: Calithera Biosciences's Earnings

Calithera Biosciences (NASDAQ:CALA) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Calithera Biosciences will report an earnings per share (EPS) of $-0.24.

Earnings Outlook For Biocept

Earnings Outlook For Biocept

Biocept (NASDAQ:BIOC) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Biocept will report an earnings per share (EPS) of $-0.19.

Earnings Preview: Dare Bioscience

Earnings Preview: Dare Bioscience

Dare Bioscience (NASDAQ:DARE) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Dare Bioscience will report an earnings per share (EPS) of $-0.15.

Analyst Ratings For PepsiCo

Analyst Ratings For PepsiCo

Analysts have provided the following ratings for PepsiCo (NASDAQ:PEP) within the last quarter:

What 4 Analyst Ratings Have To Say About Academy Sports

What 4 Analyst Ratings Have To Say About Academy Sports

Over the past 3 months, 4 analysts have published their opinion on Academy Sports (NASDAQ:ASO) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Peering Into Adagio Therapeutics Inc. - Common Stock's Recent Short Interest

Peering Into Adagio Therapeutics Inc. - Common Stock's Recent Short Interest

Adagio Therapeutics Inc. - Common Stock's (NASDAQ:ADGI) short percent of float has fallen 11.69% since its last report. The company recently reported that it has 5.28 million shares sold short, which is 12.92% of all regular shares that are available for trading.

Apple Vs. Microsoft: A Race To New All-Time Highs

Apple Inc (NASDAQ: AAPL) and Microsoft Corporation (NASDAQ: MSFT) are brand names you will of course be familiar with — and two tech giants whose stock prices have moved 600% since 2015.

Get all your
news in one place.

100's of premium titles.
One news app.

Here's How Much $100 Invested In Lululemon Athletica 10 Years Ago Would Be Worth Today

Lululemon Athletica (NASDAQ:LULU) has outperformed the market over the past 10 years by 4.41% on an annualized basis producing an average annual return of 16.94%. Currently, Lululemon Athletica has a market capitalization of $47.43 billion.

Expert Ratings For Costco Wholesale

Within the last quarter, Costco Wholesale (NASDAQ:COST) has observed the following analyst ratings:

Earnings Preview: Walgreens Boots Alliance

Walgreens Boots Alliance (NASDAQ:WBA) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Walgreens Boots Alliance will report an earnings per share (EPS) of $1.38.

Rail Vision Ltd IPOs Tomorrow, Here's What You Need To Know

Rail Vision Ltd (NASDAQ:RVSN) IPO will take place March, 31 on the NASDAQ exchange under the ticker RVSN. The company is offering shares at an expected price between $4.13 and $5.87 per share with an insider lock-up period of 180 days ending on September 27, 2022.

Get all your
news in one place.

100's of premium titles.
One news app.

Looking Into Stronghold Digital Mining's Return On Invested Capital

Stronghold Digital Mining (NASDAQ:SDIG) brought in sales totaling $17.01 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 178.56%, resulting in a loss of $17.49 million.

Microvast Holdings's Return On Capital Employed Insights

According to Benzinga Pro data, during Q4, Microvast Holdings (NASDAQ:MVST) posted sales of $48.12 million. Earnings were up 59.96%, but Microvast Holdings still reported an overall loss of $46.64 million.

Looking Into SenesTech's Return On Capital Employed

SenesTech (NASDAQ:SNES) brought in sales totaling $169.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 10.7%, resulting in a loss of $2.49 million.

Urban-gro's Return On Capital Employed Insights

Benzinga Pro data, Urban-gro (NASDAQ:UGRO) reported Q4 sales of $18.96 million. Earnings fell to a loss of $604.18 thousand, resulting in a 1112.78% decrease from last quarter.

Dyadic International Earnings Perspective: Return On Capital Employed

Dyadic International (NASDAQ:DYAI) brought in sales totaling $313.29 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 145.67%, resulting in a loss of $4.21 million.

Infinity Pharmaceuticals Earnings Perspective: Return On Capital Employed

Infinity Pharmaceuticals (NASDAQ:INFI) brought in sales totaling $451.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 8.76%, resulting in a loss of $11.65 million.

Looking Into HTG Molecular Diagnostics's Return On Capital Employed

HTG Molecular Diagnostics (NASDAQ:HTGM) brought in sales totaling $2.88 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 15.6%, resulting in a loss of $5.19 million.

1 … 757 758 759 760

Organisations

Microsoft Corporation

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play